Prevalence of depression and its association with quality of life in clinically stable patients with COVID-19

Yu-Fen Ma,Wen Li,Hai-Bao Deng,Lei Wang,Ying Wang,Pei-Hong Wang,Hai-Xin Bo,Jing Cao,Yu Wang,Li-Yun Zhu,Yuan Yang,Teris Cheung,Chee H. Ng,Xinjuan Wu,Yu-Tao Xiang
DOI: https://doi.org/10.1016/j.jad.2020.06.033
IF: 6.533
2020-10-01
Journal of Affective Disorders
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Introduction</h3><p>High risk of mental health problems is associated with Coronavirus Disease 2019 (COVID-19). This study explored the prevalence of depressive symptoms (depression hereafter) and its relationship with quality of life (QOL) in clinically stable patients with COVID-19.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>This was an online survey conducted in COVID-19 patients across five designated isolation hospitals for COVID-19 in Hubei province, China. Depression and QOL were assessed with standardized instruments.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>A total of 770 participants were included. The prevalence of depression was 43.1% (95%CI: 39.6%-46.6%). Binary logistic regression analysis found that having a family member infected with COVID-19 (OR=1.51, <em>P</em> <em>=</em> 0.01), suffering from severe COVID-19 infection (OR=1.67, <em>P</em> <em>=</em> 0.03), male gender (OR=0.53, <em>P&lt;</em>0.01), and frequent social media use to obtain COVID-19 related information (OR=0.65, <em>P&lt;</em>0.01) were independently associated with depression. Patients with depression had lower QOL than those without.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>Depression is highly prevalent in clinically stable patients with COVID-19. Regular screening and appropriate treatment of depression are urgently warranted for this population.</p>
psychiatry,clinical neurology
What problem does this paper attempt to address?